Skip to main content
katharina-beyer

Dr Katharina Beyer

Visiting Research Associate

Biography

Katharina Beyer is a  Research Associate for the Translational Oncology and Urology Research (TOUR) team. She joined in September 2018 and is currently working as the research associate for the PIONEER project, where she works on development and standardisation of a core outcome set of clinically relevant standardised prostate cancer-related outcomes and prognostic and diagnostic factors.  

In addition, she is pursuing her part time PhD focusing on patient treatment choices in kidney cancer. This research project aims to determine the most influential facilitators in kidney cancer treatment selection by comparing three different clinical units and models of care in the UK.

She received her BSc in European Public Health from Maastricht University in the Netherlands, followed by her MSc, a double degree in Public Policy and Human Development from the United Nations University Institute for Economic and Social Research on Innovation and Technology and Maastricht University. She wrote her MSc dissertation as part of a research project of the Wellcome Trust Expert Advisory Group on Data Access.

Research

tour-logo
Translational Oncology and Urology Research

The Translational Oncology and Urology Research (TOUR) team aims to turn science into better healthcare by translating uro-oncology research into medical practice.

Features

5 minutes with Katharina Beyer

Katharina Beyer is a Research Associate for the Translational Oncology and Urology Research Team, within the School of Cancer and Pharmaceutical Sciences.

5-minutes-with-katharina-beyer

Research

tour-logo
Translational Oncology and Urology Research

The Translational Oncology and Urology Research (TOUR) team aims to turn science into better healthcare by translating uro-oncology research into medical practice.

Features

5 minutes with Katharina Beyer

Katharina Beyer is a Research Associate for the Translational Oncology and Urology Research Team, within the School of Cancer and Pharmaceutical Sciences.

5-minutes-with-katharina-beyer